SUPN vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 24, 2026

SUPN

57.9
AI Score
VS
PCRX Wins

PCRX

64.1
AI Score

Investment Advisor Scores

SUPN

58score
Recommendation
HOLD

PCRX

64score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric SUPN PCRX Winner
Forward P/E 20.1613 7.7519 PCRX
PEG Ratio 1.47 11.2121 SUPN
Revenue Growth 38.6% 5.0% SUPN
Earnings Growth 11.1% -30.0% SUPN
Tradestie Score 57.9/100 64.1/100 PCRX
Profit Margin -3.7% 0.7% PCRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY PCRX

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.